Psychedelic Medicine

Association

Ketamine reduces the neural distinction between self- and other-produced affective touch – a double-blind placebo-controlled study

Excerpts from the publication

A coherent sense of self is crucial for social functioning and mental health. The N-methyl-D-aspartate antagonist ketamine induces short-term dissociative experiences and has therefore been used to model an altered state of self-perception. However, the mechanisms for its effects on the bodily sense of self remain largely unknown. In this randomized double-blind placebo-controlled within-subject study, 30 participants received intravenous ketamine while performing a previously validated task during functional MRI: self-touch and touch by someone else were used as a measure of self-other-distinction. Afterwards, tactile detection thresholds during self- and other-touch were assessed, as well as dissociative states, interoceptive awareness, and social touch attitudes. Compared to placebo, ketamine administration induced a higher state of dissociation and a reduction of self-other distinction in the temporoparietal cortex. This reduction correlated with ketamine-related reductions in interoceptive awareness. Our results indicate that disrupting the self-experience by ketamine-administration affects self-other-distinction in a region associated with touch perception and social cognition. This process may be driven by ketamine-induced effects on top-down signaling, rendering the processing of predictable self-generated and unpredictable other-generated touch more similar. Our findings provide further evidence for the intricate relationship of the bodily self with social touch.

Read more

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Ketamine reduces the neural distinction between self- and other-produced affective touch – a double-blind placebo-controlled study

Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life

Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers